NEW YORK, Sept. 17, 2012 /PRNewswire via COMTEX/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced that Cytomedix, Inc. (OTCQX: CMXI), a fully integrated regenerative medicine company, is now trading on the highest OTC marketplace, OTCQX?.

(Logo:  http://photos.prnewswire.com/prnh/20110118/MM31963LOGO )

Cytomedix upgraded from OTCQB today to trade on the OTC market's prestigious marketplace, OTCQX U.S. Investors can find current financial disclosure and Real-Time Level 2 quotes for the Company on  www.otcmarkets.com .

"OTCQX provides services to companies which enable them to communicate with and engage their investors, while providing them with transparent trading and easy access to company information," said R. Cromwell Coulson, President and Chief Executive Officer of OTC Markets Group. "We are pleased to welcome Cytomedix to OTCQX."